SGLT2 Inhibition in Acute Myocardial Infarction—A Comprehensive Review

SGLT2 Inhibition in Acute Myocardial Infarction—A Comprehensive Review

In heart failure as well as in chronic kidney disease sodium-glucose cotransporter 2 (SGLT2) inhibitors have changed the landscape of medical therapy. Originally developed for use in diabetes, an unforeseen cardiovascular benefit extended SGLT2 inhibitor use from antihyperglycemic agents to cardiova...

Full description

Bibliographic Details
Main Authors: Martin Benedikt, Ewald Kolesnik, Harald Sourij, Dirk von Lewinski
Format: Article
Language:English
Published: IMR Press 2023-01-01
Series:Reviews in Cardiovascular Medicine
Subjects:
sglt2
myocardial infarction
metabolism
inflammation
Online Access:https://www.imrpress.com/journal/RCM/24/2/10.31083/j.rcm2402032

Similar Items

Similar Items